Tesaro execs split $304M windfall from $5.1B GlaxoSmithKline buyout

Tesaro execs split $304M windfall from $5.1B GlaxoSmithKline buyout

Source: 
Endpoints
snippet: 


Tesaro CEO Lonnie Moulder may not have landed the deal he originally wanted for selling the biotech, but he’s not exactly coming away empty-handed.